Physician
Lwin, Zaw
Lwin, Zaw was paid $775.84 by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 94% of everything it billed.
33Billing provider infoLWIN, ZAW
LOS ANGELES, CA 90003
LOS ANGELES, CA 90003
33aNPI1437257912assigned 09/20/2006
33bProvider typeAdult Medicine Physician
28Total paid$775.84
24GClaims24,999
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Adult Medicine Physician providers in California
Rank by total paid#48 of 72
Median peer was paid$4K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,144 | $364.32 | |
| 2019 | 791 | $411.52 | |
| 2020 | 2,725 | $0.00 | |
| 2021 | 4,321 | $0.00 | |
| 2022 | 4,481 | $0.00 | |
| 2023 | 4,608 | $0.00 | |
| 2024incomplete | 6,929 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 94% | 1,580 | 1,206 | $726.34 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 1,107 | 1,068 | $37.50 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.5% | 2,069 | 1,815 | $12.00 |
| 80061 | Lipid panel | 0% | 1,666 | 1,662 | $0.00 |
| 82540 | 0% | 684 | 683 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 115 | 114 | $0.00 |
| 86703 | 0% | 719 | 714 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 86 | 82 | $0.00 |
| 84439 | 0% | 30 | 28 | $0.00 | |
| 84450 | 0% | 106 | 106 | $0.00 | |
| 3078F | 0% | 608 | 532 | $0.00 | |
| 82274 | 0% | 265 | 265 | $0.00 |
34 more codes
| 84460 | 0% | 86 | $0.00 | |
| 3077F | 0% | 180 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 26 | $0.00 |
| 99442 | 0% | 67 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 12 | $0.00 |
| 85027 | 0% | 974 | $0.00 | |
| 1111F | 0% | 208 | $0.00 | |
| 99443 | 0% | 666 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 1,315 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 820 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 686 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,897 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,400 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 953 | $0.00 |
| 3079F | 0% | 164 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 725 | $0.00 |
| 82043 | 0% | 684 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 115 | $0.00 |
| 3074F | 0% | 477 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 381 | $0.00 |
| 86140 | 0% | 14 | $0.00 | |
| 3075F | 0% | 165 | $0.00 | |
| 81001 | 0% | 27 | $0.00 | |
| 1220F | 0% | 320 | $0.00 | |
| 90656 | 0% | 22 | $0.00 | |
| 86780 | 0% | 49 | $0.00 | |
| 86593 | 0% | 73 | $0.00 | |
| 3044F | 0% | 230 | $0.00 | |
| 90686 | 0% | 37 | $0.00 | |
| 3080F | 0% | 46 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 24 | $0.00 |
| 4450F | 0% | 68 | $0.00 | |
| 94760 | 0% | 12 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.